SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-19-003792
Filing Date
2019-06-03
Accepted
2019-06-03 16:48:37
Documents
6
Period of Report
2019-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_060319.htm 8-K 14884
2 PRESS RELEASE exh_11.htm EX-1.1 199372
3 PRESS RELEASE exh_51.htm EX-5.1 14788
4 PRESS RELEASE exh_991.htm EX-99.1 5566
5 logo_51.jpg GRAPHIC 3123
6 logo_512.jpg GRAPHIC 12428
  Complete submission text file 0001171843-19-003792.txt   257437
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37347 | Film No.: 19873877
SIC: 2834 Pharmaceutical Preparations